TriSalus Life Sciences (TLSI) Institutional Ownership $5.12 +0.22 (+4.49%) As of 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for TriSalus Life Sciences (NASDAQ:TLSI)CurrentInstitutional OwnershipPercentage2.58%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$4.60MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$295.22K Get TLSI Insider Trade Alerts Want to know when executives and insiders are buying or selling TriSalus Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TLSI Institutional Buying and Selling by Quarter TriSalus Life Sciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025Goldman Sachs Group Inc.33,900$187K0.0%N/A0.090% 5/16/2025Goldman Sachs Group Inc.33,900$187K0.0%N/A0.105% 5/9/2025Charles Schwab Investment Management Inc.10,000$55K0.0%N/A0.031% 2/18/2025Connecticut Wealth Management LLC22,303$112K0.0%-32.2%0.073% 2/18/2025Connective Capital Management LLC27,989$140K0.2%N/A0.092% 2/17/2025Millennium Management LLC80,538$403K0.0%-17.7%0.264% 2/17/2025Bridgeway Capital Management LLC65,000$326K0.0%+333.3%0.213% 2/17/2025Bank of America Corp DE178,446$894K0.0%+120,471.6%0.585% 2/17/2025Angelo Gordon & CO. L.P.10,854$54K0.0%-48.0%0.036% 2/14/2025Lido Advisors LLC14,024$70K0.0%-60.0%0.046% Get the Latest News and Ratings for TLSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025Northern Trust Corp32,112$161K0.0%+22.7%0.105% 2/13/2025Renaissance Technologies LLC13,400$67K0.0%N/A0.044% 2/12/2025Geode Capital Management LLC204,137$1.02M0.0%+1.9%0.670% 11/20/2024Virtu Financial LLC19,875$92K0.0%N/A0.065% 11/16/2024Geode Capital Management LLC200,427$924K0.0%+45.4%0.657% 11/15/2024Vestcor Inc23,376$108K0.0%N/A0.077% 11/15/2024MSD Partners L.P.39,999$184K0.1%N/A0.131% 11/14/2024Walleye Capital LLC14,376$66K0.0%N/A0.047% 8/15/2024Duquesne Family Office LLC426,921$2.36M0.1%+35.1%1.572% 8/12/2024Highbridge Capital Management LLC214,545$1.18M0.0%N/A0.790% 8/2/2024Wolverine Asset Management LLC43,480$240K0.0%N/A0.160% 5/7/2024Anson Capital Inc.24,415$238K0.3%-30.3%0.091% 5/1/2024Connecticut Wealth Management LLC44,606$435K0.0%-22.0%0.167% 4/23/2024Tyche Wealth Partners LLC10,000$98K0.0%-62.5%0.037% 1/30/2024Tyche Wealth Partners LLC26,664$225K0.1%N/A0.101% 1/25/2024HC Advisors LLC101,736$860K0.5%N/A0.387% (Data available from 1/1/2016 forward) TLSI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TLSI shares? During the previous two years, 22 institutional investors and hedge funds held shares of TriSalus Life Sciences. The most heavily invested institutionals were Duquesne Family Office LLC ($2.36M), Highbridge Capital Management LLC ($1.18M), Geode Capital Management LLC ($1.02M), Bank of America Corp DE ($894K), HC Advisors LLC ($860K), Millennium Management LLC ($403K), and Bridgeway Capital Management LLC ($326K).Learn more on TriSalus Life Sciences' institutional investors. What percentage of TriSalus Life Sciences' stock is owned by institutional investors? 2.58% of TriSalus Life Sciences' stock is owned by institutional investors. Learn more on TLSI's institutional investor holdings. Which institutional investors have been buying TriSalus Life Sciences' stock? Of the 17 institutional investors that purchased TriSalus Life Sciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Highbridge Capital Management LLC ($214.55K), Bank of America Corp DE ($178.30K), Duquesne Family Office LLC ($110.97K), HC Advisors LLC ($101.74K), Goldman Sachs Group Inc. ($67.80K), Geode Capital Management LLC ($66.25K), and Bridgeway Capital Management LLC ($50K). How much institutional buying is happening at TriSalus Life Sciences? Institutional investors have bought a total of 886,292 shares in the last 24 months. This purchase volume represents approximately $4.60M in transactions. Which of TriSalus Life Sciences' major shareholders have been selling company stock? The following institutional investors have sold TriSalus Life Sciences stock in the last 24 months: Lido Advisors LLC ($21K), Millennium Management LLC ($17.35K), Connecticut Wealth Management LLC ($10.58K), and Angelo Gordon & CO. L.P. ($10K). How much institutional selling is happening at TriSalus Life Sciences? Institutional investors have sold a total of 58,926 shares in the last 24 months. This volume of shares sold represents approximately $295.22K in transactions. Related Companies iRadimed Institutional Ownership CeriBell Institutional Ownership Beta Bionics Institutional Ownership Embecta Institutional Ownership Avanos Medical Institutional Ownership Bioventus Institutional Ownership OrthoPediatrics Institutional Ownership RxSight Institutional Ownership Butterfly Network Institutional Ownership AxoGen Institutional Ownership This page (NASDAQ:TLSI) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
